The Cochlear Limited (ASX: COH) share price has been charging higher again on Wednesday.
In morning trade, the hearing solutions company’s shares are up 7% to $222.02.
This means the Cochlear share price is now up over 16% in the space of two days.
Why is the Cochlear share price storming higher?
Investors have been bidding the Cochlear share price higher since the release of a stronger than expected half year result.
For the six months ended 31 December, Cochlear delivered a 26% increase in half year underlying net profit to $158 million. This was well ahead of the market consensus estimate and has led to many brokers upgrading their estimates and recommendations.
One of those is the team at Goldman Sachs.
What did Goldman say?
According to a note this morning, the broker has upgraded the company’s shares to a buy rating with a $237.00 price target.
It was very pleased with its performance and notes that Cochlear is a “clear leader in a defensive industry with improving fundamentals.”
Goldman commented: “There is little doubt around the long-term, defensive nature of the cochlear implant (CI) market, or COH’s competitive position within it. Rather, the largest recent debates have revolved around the extent to which surgery restrictions, staffing limitations and changes to patient/physician behaviour will preclude a strong volume profile from returning.”
“Whilst volatility clearly remains, on all fronts we are now more comfortable than any time since the start of the pandemic. Even after today’s +5% upgrade, we believe guidance appears more realistic/beatable than for several years (COH has shown a mixed track record in this regard for some time). Covid-driven disruption is falling in most key markets, and we see scope for a clear sequential improvement in both earnings and sentiment towards this stock,” it added.
Goldman Sachs also highlights the company’s huge cash balance of $506 million. It notes that “COH has little need to maintain such a material cash balance and, as conditions continue to improve, we expect management to more strongly prioritise any number of accretive deployment opportunities.”
The post ‘Clear leader in a defensive industry’: Cochlear (ASX:COH) share price jumps on broker upgrade appeared first on The Motley Fool Australia.
Should you invest $1,000 in Cochlear right now?
Before you consider Cochlear, you’ll want to hear this.
Motley Fool Investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Cochlear wasn’t one of them.
The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.* And right now, Scott thinks there are 5 stocks that are better buys.
*Returns as of January 13th 2022
More reading
- Here are the top 10 ASX shares today
- ASX 200 tech shares take a hammering as Ukraine fears escalate
- Why Cochlear, Coles, Costa, and Monadelphous shares are racing higher
- ASX 200 (ASX:XJO) midday update: Coles and Cochlear impress, Nanosonics sinks
- Cochlear (ASX:COH) share price 6% higher on juicy 35% dividend spike
Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns and has recommended Cochlear Ltd. The Motley Fool Australia has recommended Cochlear Ltd. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.
from The Motley Fool Australia https://ift.tt/xoaEHdR
Leave a Reply